156 related articles for article (PubMed ID: 32911782)
1. Cerebral Vasodilator Property of Poly(ADP-Ribose) Polymerase Inhibitor (PJ34) in the Neonatal and Adult Mouse Is Mediated by the Nitric Oxide Pathway.
Bonnin P; Charriaut-Marlangue C; Pansiot J; Boutigny A; Launay JM; Besson VC
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911782
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Reduces Brain Damage after Stroke in the Neonatal Mouse Brain.
Bonnin P; Vitalis T; Schwendimann L; Boutigny A; Mohamedi N; Besson VC; Charriaut-Marlangue C
Curr Issues Mol Biol; 2021 Jun; 43(1):301-312. PubMed ID: 34200155
[TBL] [Abstract][Full Text] [Related]
3. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.
Tao X; Chen X; Hou Z; Hao S; Liu B
World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177
[TBL] [Abstract][Full Text] [Related]
4. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.
Tao X; Chen X; Hao S; Hou Z; Lu T; Sun M; Liu B
Neuroscience; 2015 Apr; 291():26-36. PubMed ID: 25668593
[TBL] [Abstract][Full Text] [Related]
5. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury.
Park EM; Cho S; Frys K; Racchumi G; Zhou P; Anrather J; Iadecola C
Stroke; 2004 Dec; 35(12):2896-901. PubMed ID: 15514191
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in the effects of PARP inhibition on microglial phenotypes following neonatal stroke.
Charriaut-Marlangue C; Leconte C; Csaba Z; Chafa L; Pansiot J; Talatizi M; Simon K; Moretti R; Marchand-Leroux C; Baud O; Besson VC
Brain Behav Immun; 2018 Oct; 73():375-389. PubMed ID: 29852289
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice.
Huang S; Zhang B; Chen Y; Liu H; Liu Y; Li X; Bao Z; Song Z; Wang Z
J Pharmacol Exp Ther; 2018 Mar; 364(3):452-461. PubMed ID: 29317476
[TBL] [Abstract][Full Text] [Related]
8. Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis.
Zhou X; Patel D; Sen S; Shanmugam V; Sidawy A; Mishra L; Nguyen BN
J Vasc Surg; 2017 Apr; 65(4):1161-1169. PubMed ID: 27288104
[TBL] [Abstract][Full Text] [Related]
9. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection.
McCullough LD; Zeng Z; Blizzard KK; Debchoudhury I; Hurn PD
J Cereb Blood Flow Metab; 2005 Apr; 25(4):502-12. PubMed ID: 15689952
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of proliferation and invasiveness of ovarian cancer C13* cells by a poly(ADP-ribose) polymerase inhibitor and the role of nuclear factor-κB.
Wang Z; Li Y; Lv S; Tian Y
J Int Med Res; 2013 Oct; 41(5):1577-85. PubMed ID: 24097829
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice.
Haddad M; Rhinn H; Bloquel C; Coqueran B; Szabó C; Plotkine M; Scherman D; Margaill I
Br J Pharmacol; 2006 Sep; 149(1):23-30. PubMed ID: 16865091
[TBL] [Abstract][Full Text] [Related]
12. Administration of the PARP inhibitor Pj34 ameliorates the impaired vascular function associated with eNOS(-/-) mice.
English FA; McCarthy FP; Andersson IJ; Stanley JL; Davidge ST; Baker PN; Walsh SK; Kenny LC
Reprod Sci; 2012 Aug; 19(8):806-13. PubMed ID: 22421449
[TBL] [Abstract][Full Text] [Related]
13. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Poly(ADP-Ribose) Polymerase Increased Lipid Accumulation Through SREBP1 Modulation.
Pang J; Cui J; Xi C; Shen T; Gong H; Dou L; Lin Y; Zhang T
Cell Physiol Biochem; 2018; 49(2):645-652. PubMed ID: 30165350
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
16. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.
Haddad M; Beray-Berthat V; Coqueran B; Palmier B; Szabo C; Plotkine M; Margaill I
Eur J Pharmacol; 2008 Jun; 588(1):52-7. PubMed ID: 18468597
[TBL] [Abstract][Full Text] [Related]
17. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.
Black JH; Casey PJ; Albadawi H; Cambria RP; Watkins MT
J Am Coll Surg; 2006 Jul; 203(1):44-53. PubMed ID: 16798486
[TBL] [Abstract][Full Text] [Related]
18. Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?
Lechaftois M; Dreano E; Palmier B; Margaill I; Marchand-Leroux C; Bachelot-Loza C; Lerouet D
PLoS One; 2014; 9(10):e110776. PubMed ID: 25329809
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC
J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase.
Mabley JG; Jagtap P; Perretti M; Getting SJ; Salzman AL; Virág L; Szabó E; Soriano FG; Liaudet L; Abdelkarim GE; Haskó G; Marton A; Southan GJ; Szabó C
Inflamm Res; 2001 Nov; 50(11):561-9. PubMed ID: 11766996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
